Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Immunocore Holdings plcIMCR · Entity 4544 | Director | May 27, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Immunocore Holdings plc
Report date May 27, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.52 · Expires 2036-05-26 | Direct | 27,492 |
Reported balance
After 2026-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 27,492 · Balance 27,492 F1: The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2026 Filed May 28, 2026 23:55 UTC | Immunocore Holdings plc IMCR · Entity 4544 | GrantShare Option (Right to Buy) · Derivative | 27,492 | $0.00 Strike: $28.52 | $0.00 |
DisclosureSEC source: 0001969520-26-000002 · form4-05282026_070503.xml · derivative · entry 1 Herbst Roy Steven · CIK 0001969520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,492 Underlying: Ordinary Shares · 27,492 shares Expires 2036-05-26 F1 · derivative.exercise_date: The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:15 UTC | Immunocore Holdings plc IMCR · Entity 4544 | GrantShare Option (Right to Buy) · Derivative | 26,198 | $0.00 Strike: $29.06 | $0.00 |
DisclosureSEC source: 0001415889-25-013625 · form4-05192025_040510.xml · derivative · entry 1 Herbst Roy Steven · CIK 0001969520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,198 Underlying: Ordinary Shares · 26,198 shares Expires 2035-05-14 F1 · derivative.exercise_date: The shares subject to the option award shall vest at the earlier of (i) May 15, 2026 and (ii) the day immediately prior to the date of our next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:15 UTC | Immunocore Holdings plc IMCR · Entity 4544 | GrantShare Option (Right to Buy) · Derivative | 14,534 | $0.00 Strike: $50.47 | $0.00 |
DisclosureSEC source: 0001415889-24-014654 · form4-05282024_040504.xml · derivative · entry 1 Herbst Roy Steven · CIK 0001969520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,534 Underlying: Ordinary Shares · 14,534 shares Expires 2034-05-22 F1 · derivative.exercise_date: The shares subject to the option award shall vest at the earlier of (i) May 23, 2025 and (ii) the day immediately prior to the date of our next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.